Introduction {#s1}
============

Multidrug resistance P-glycoproteins, Mdr2 in mouse and MDR3 in human, are the choline-containing phospholipid phosphatidylcholine (PC) transporters that belong to the subfamily B4 of ATP-binding cassette transporters (ABCB4) ([@CIT0001]). In the liver, Mdr2/MDR3 are involved in the translocation of PC from the inner leaflet to the outer leaflet of the canalicular membrane of hepatocytes for direct extraction by bile acids (BA). BA and PC are essential components in the bile that form BA micelles to reduce the toxic detergent activity of BA for hepatocytes and cholangiocytes and to establish physiological bile flow. Mutations in the *ABCB4* gene in human result in deficiency of PC in the bile, causing diseases including progressive familial intrahepatic cholestasis type 3 (PFIC3), intrahepatic cholestasis of pregnancy and low-phospholipid-associated cholelithiasis ([@CIT0002]). A constitutive *Mdr2* knockout mouse has been generated, which successively develops liver inflammation, hepatic fibrosis and hepatocellular carcinoma (HCC) at late ages ([@CIT0003]). The pathogenesis in *Mdr2* ^*−/−*^ mice is commonly considered to be caused by toxic BA in the biliary canaliculus, which damages hepatocytes and cholangiocytes and provokes liver inflammation. However, the contribution of ABCB4 deficiency to the development of the pathologies has been largely unknown.

The ABC transporters are integral membrane proteins. The plasma membrane displays an asymmetric arrangement of the various phospholipids, with PC and sphingomyelin enriched in the exoplasmic leaflet and the aminophospholipids phosphatidylserine and phosphatidylethanolamine in the cytosolic leaflet ([@CIT0004]). MDR3 can influence lipid components at the plasma membrane, as it has been shown that exogeneous MDR3 expression in HEK293 cells increased sphingomyelin and cholesterol enrichment in lipid rafts ([@CIT0005]). Moreover, expression of MDR3 alters lipid composition on the envelop of HIV vector, thus reducing viral infectivity ([@CIT0006]). MDR3-mediated transport of PC at the cell membrane results in the formation of lipid vesicles, which induces cholesterol diffusion from cell membrane ([@CIT0007]). These observations suggest that Mdr2/MDR3 are not only the PC transporters for bile formation, but also play a role in the maintenance of lipid homeostasis. Indeed, a previous report showed association of alterations in lipid metabolism and liver pathogenesis in *Mdr2* ^*−/−*^ mice ([@CIT0008]).

Although hepatocytes are the major cell type in which Mdr2/MDR3 are expressed, Mdr2/MDR3 mRNAs have been detected in many tissues such as adrenal glands, muscle, tonsil and spleen and various cell types including T and B lymphocytes, epithelial cells and fibroblasts ([@CIT0009],[@CIT0010]). In this study, we used mouse embryonic fibroblasts (MEF) isolated from *Mdr2* ^*−/−*^ embryos to investigate if Mdr2 deficiency impacts on other cell functions than bile formation. We found accumulated reactive oxygen species (ROS), increased lipid peroxidation and DNA damages in *Mdr2* ^*−/−*^ MEFs. These findings were corroborated by observations in *Mdr2* ^*−/−*^ liver. Our results imply that Mdr2 deficiency can contribute to liver diseases through perturbation of ROS homeostasis and underscore possible extrahepatic functions of Mdr2.

Materials and methods {#s2}
=====================

Animals {#s3}
-------

*Mdr2* ^*−/−*^ (FVB.129P2-*Abcb4* ^*tm1Bor*^/J) and WT FVB/NCrl mice were obtained from The Jackson Laboratory. *Mdr2* ^*−/−*^ mice were first mated to WT mice to generate *Mdr2* ^*−/+*^ animals. Intercrossing *Mdr2* ^*−/+*^ animals gave rise to *Mdr2* ^*−/−*^ and *Mdr2* ^*+/+*^ littermates. All the experiments were performed with age- and sex-matched *Mdr2* ^*−/−*^ and *Mdr2* ^*+/+*^ littermates. For azoxymethane (AOM) and dextran sodium sulfate (DSS)-induced intestinal tumorigenesis, female mice were used. Experimental procedures were approved by Ethic Committee Paris Center and South in accordance with the French government regulations. Mice were bred in a pathogen-free environment at the Institut Pasteur animal facility in accordance with welfare criteria outlined in the 'Guide for the Care and Use of Laboratory Animals'.

Cell culture {#s4}
------------

MEF and derivatives, established and extensively characterized by us at the Institut Pasteur during this study, were derived from *Mdr2* ^*−/−*^, *Mdr2* ^*−/+*^ and *Mdr2* ^*+/+*^ littermate embryos on day 13.5 generated by intercrossing *Mdr2* ^*−/+*^ mice. Spontaneously immortalized cell lines were established using 3T3 protocol as described ([@CIT0011]). Three independent MEFs preparations were performed. The earliest frozen stocks of all cell lines have been stored in nitrogen containers at the Institut Pasteur. We have propagated cells from frozen stocks of the original vials that were authenticated by qPCR on the expression of Mdr2. The validation of the identity of cells at the earliest stocks or grown \>20 passages was tested on regular basis. MEFs were cultured in Dulbecco's modified Eagle medium (DMEM (1×)-glutaMAX^TM^-I supplemented with 10% fetal bovine serum, in 95% air and 5% CO~2~ atmosphere and humidified incubator at 37°C. To measure cell proliferation, MEFs were plated at a density of 2×10^4^ cells into six-well plates in triplicate. Cell numbers were determined using a Z1 Coulter Counter® (Beckman Coulter). To examine resistance to doxorubicin (Dox)-induced apoptosis, 2×10^3^ primary and immortalized MEFs were seeded into 96-well plates and treated with increasing doses of Dox for 2h. Cell viability was measured with MTT assay.

Mdr2 cDNA was synthesized and cloned in pCMV6 by OriGene and stably transfected into *Mdr2* ^*−/−*^ MEFs by Lipofectamine 2000 (Life Technologies) followed by G418 selection.

RNA analysis {#s5}
------------

For qPCR, total RNA was isolated from cells, mouse livers and mouse intestines with RNeasy minikit (Qiagen). 1 μg of RNA was reverse-transcribed using random primers and the cDNA Sythesis Kit (Life Technologies). The mean copy number of each gene from a triplicate determination was normalized to the mean copy number of hypoxanthine-guanine phosphoribosyltransferase. The sequences of primers used for qPCR are: mouse *Mdr2* 5′-GAGCAAAGTCCAGGTCTGC-3′, 5′-TGCTGCCTAGTTCAAAGTCG-3′; mouse *Mdr1a* 5′-CAACATCCACCAGTTCATCG-3′, 5′-AATGTGAGGCTGT CTGACGA-3′; mouse *Mdr1b* 5′-tgggtgcatacaaccagtgt-3′, 5′-tcagccccataaccagaaag-3′. The sequences of hypoxanthine-guanine phosphoribosyltransferase were published previously ([@CIT0012]).

For microarray experiment, 50ng of total RNA from MEFs was reverse transcribed and amplified using the Ovation Pico WTA System v2 (Nugen Technologies, Inc. \#3302--12), cDNA was biotin labeled before hybridization on Affymetrix Genechip Mouse Gene 2.0 ST Array. Two independent WT and three independent *Mdr2* ^*−/−*^ primary or immortalized MEF clones were profiled via microarrays according to the 'Target Preparation for Affymetrix GeneChip® Eukaryotic Array Analysis' protocol. Microarray data are available through the Gene Expression Omnibus (GEO) database under accession number GSE72615.

CAGE libraries (for Cap Analysis of Gene Expression) with total RNA extracted from WT or *Mdr2* ^*−/−*^ livers were constructed following the protocol reported previously ([@CIT0013]). About 5 μg of total RNA was used to synthesize cDNA with random primers. Full-length cDNAs were biotinylated and captured by streptavidin-coated magnetic beads. The cDNAs were released from cap-trapped RNAs, ligated to 5′ linkers including barcode sequences, and digested with EcoP15I. CAGE libraries were sequenced with single-end reads of 50bp on the Illumina HiSeq 2000 platform. CAGE data are available through GEO database under accession number GSE60982.

Microarray and CAGE data analyses {#s6}
---------------------------------

After quality assessment and normalization of the arrays, gene-level expression values were derived from the CEL file probe-level hybridization intensities using the model-based Robust Multichip Average algorithm. The estimated false discovery rate (FDR) of the local pooled error test was calculated using the BH approach. The list of deregulated genes in biological processes analyzed using the Gene Ontology is available upon request.

For CAGE data analysis, differentially expressed genes between tumor versus normal were identified using a Bayesian T-test ([@CIT0014]) on the normalized data. For each *P* value, the Benjamini--Hochberg procedure was used to calculate the FDR to avoid the problem of multiple testing ([@CIT0015]). The significant genes were selected using 0.05 as threshold for the FDR.

For each pair of genes we computed the Spearman Correlation Coefficient (SCC) obtaining a correlation coefficient matrix. We estimated the SCC significance for each pair of genes by computing *t*-statistics of each SCC value and then using Student's *t*-test distribution to estimate the *P* value. To control the number of false positives owing to the multiple hypotheses test problem, we estimated the degrees of freedom of the *t*-test distribution from the data by fitting the parameters of a Student's t-location-scale distribution to the *t* statistics computed for all the genes pairs. We estimated the parameters by minimizing the squared error between the theoretical and the empirical distribution. We then generated a network by connecting two genes if the associated SCC was significant (corrected *P \<* 0.05). From the total network, we extracted the subnetwork of the significant differentially expressed genes and the groups of densely interconnected genes (i.e. communities) were detected via the Walktrap Algorithm by Pons and Latapy ([@CIT0016]). This algorithm uses a hierarchical agglomerative method and the distance between two nodes is defined in terms of random walks. The idea is that shorts random walks tend to stay in the same communities. We assessed that 40% of the identified communities are enriched for a specific biological function by Gene Ontology analysis performed using the Database for Annotation, Visualization and Integrated Discovery (DAVID) Functional Annotation Clustering tool ([@CIT0017]). The list of Gene Ontology enrichment for each of the community is available upon request.

Protein analysis {#s7}
----------------

1.5×10^5^ MEFs were seeded into six-well plates and synchronized by incubation in 0.5% fetal bovine serum in DMEM for 72h. Synchronized cells were stimulated by 10% fetal bovine serum in DMEM. Cellular extracts were prepared at indicated times post-stimulation and analyzed by immunoblotting. The following primary antibodies were used: cyclin D1 (sc-450), cyclin A (sc-751), β-actin (Sigma-Aldrich), caspase-3 (Cell Signaling), HP1α (Euromedex), Akt and phospho-Akt (Cell Signaling). Mitotic cells were analyzed by immunofluorescence with antibodies against phosphorylated H2AX on Ser139 and 53BP1 (Cell Signaling). Immunohistochemistry (IHC) with antibodies against phosphorylated H2AX on Ser139 and 53BP1 was performed with 4-month-old liver as described previously ([@CIT0018]).

Measurement of ROS and malondialdehyde (MDA) {#s8}
--------------------------------------------

Intracellular ROS contents were measured by flow cytometry analysis using 2,7-dichlorodihydrofluorescein diacetate dye (H~2~DCFDA, Life Technologies) as described previously ([@CIT0019]). Briefly, MEFs were treated for 1h with 0.1mM H~2~O~2,~ then allowed to recover in fresh media and harvested after 1 and 6h. Then cells were incubated in pre-warmed Hanks' balanced salt solution in the presence of 10 µM H~2~DCFDA and incubated 1h at room temperature. Dye loading buffer was then removed and replaced by pre-warmed complete growth media. Cells were incubated for 30min at 37°C to allow H~2~DCFDA oxidation generating 2,7-dichlorofluorescein (DCF), a fluorescent compound. ROS accumulation was analyzed using a MACSQuant® (Miltenyi Biotec) flow cytometer and FlowJo software.

The end product of lipid peroxidation MDA was measured using Lipid Peroxidation Assay Kit (Abcam). Cells or liver tissues were homogenized in MDA lysis buffer. Insoluble materials were removed by centrifugation. Supernatant was used for the Colorimetric Assay to quantify MDA amounts according to the Manufacturer's Protocol.

Cell transformation assays and tumorigenesis {#s9}
--------------------------------------------

For focus assay, MEFs were seeded at 150, 300 or 600 cells/well in six-well plates. After 2 weeks, cells were stained with crystal violet and colonies more than 2mm in diameter were counted under a Nikon-Eclipse TS100 light microscope. The experiments were repeated twice with two independent MEFs preparations. For soft agar assay, cells were resuspended in 0.3% agarose in DMEM at a density of 5×10^4^ cells/well in six-well plates and plated in triplicate onto solidified 0.6% agarose-containing medium. Cells grew for 4 weeks and were supplemented with fresh media two times a week. Colonies were stained by 0.005% crystal violet and counted using a light microscope. The experiments were repeated twice with different MEFs preparations. For *in vivo* tumorigenesis assays, 5×10^6^ cells were implanted s.c. into each flank of five 8-week-old female athymic BALB/c mice (Charles River Laboratories). Tumor growth was monitored with a caliper for 3 weeks. No tumor developed in control group during the period of observation of 10 weeks. The experiment was repeated once.

Intestinal tumor induction {#s10}
--------------------------

Intestinal tumors were induced by AOM and DSS according to a previous report ([@CIT0020]). 6- to 8-week-old female mice (*Mdr2* ^*+/+*^ and *Mdr2* ^*−/−*^ littermates on FVB background) were injected intraperitoneally with 10mg/kg body weight AOM (Sigma-Aldrich) and exposed seven days later to three cycles of 2.5% of Dextran Sulfate 40 Sodium (A3261, AppliChem, average molecular weight 40000g/mol) administrated in the drinking water for 7 days, followed by 14 days of regular water. Mice were killed after the last cycle. Intestines were removed from mice and fixed as 'Swiss rolls' in 4% paraformaldehyde. Tumor scoring and histopathological analysis were described previously ([@CIT0021]).

Results {#s11}
=======

Deficiency of Mdr2 in MEFs increases cell proliferation and resistance to Dox-induced apoptosis {#s12}
-----------------------------------------------------------------------------------------------

We isolated WT and *Mdr2* ^*−/−*^ MEFs derived form *Mdr2* ^*+/+*^ and *Mdr2* ^*−/−*^ littermate embryos. After confirming expression of Mdr2 mRNA by qPCR in WT MEFs ([Figure 1A](#F1){ref-type="fig"}), primary WT and *Mdr2* ^*−/−*^ cells were subjected to passages using the 3T3 protocol to obtain spontaneously immortalized cell lines. No difference in growth and senescence kinetics was observed between primary *Mdr2* ^*+/+*^, *Mdr2* ^*+/−*^ and *Mdr2* ^*−/−*^ cells ([Figure 1B](#F1){ref-type="fig"}). When primary WT and *Mdr2* ^*-/*-^ cells were subjected to serum starvation for 72h followed by serum addition, expression of the cell cycle regulators cyclin D1 and cyclin A displayed similar intensity and kinetics in response to serum stimulation ([Figure 1C](#F1){ref-type="fig"}, left panel). In sharp contrast, immortalized *Mdr2* ^*−/−*^ cells showed distinct proliferation profiles. They grew significantly faster than *Mdr2* ^*+/+*^ MEFs, whereas *Mdr2* ^*+/−*^ cells exhibited an intermediate growth rate ([Figure 1D](#F1){ref-type="fig"}). Accordingly, in *Mdr2* ^*−/−*^ cells, the kinetics of induction of cylcin D1 and cyclin A was drastically advanced in response to serum stimulation, and the levels of the induction were greatly augmented (see [Figure 1C](#F1){ref-type="fig"}, right panel).

![Loss of Mdr2 increases cell proliferation and resistance to apoptosis. (**A**) *Mdr2* mRNA expression in *Mdr2* ^*+/+*^, *Mdr2* ^*−/+*^ and *Mdr2* ^*−/−*^ MEFs at passage 3 by qPCR. (**B**) Primary *Mdr2* ^*+/+*^, *Mdr2* ^*−/+*^ and *Mdr2* ^*−/−*^ cell proliferation on a 3T3 protocol. Data shown are representative of cell proliferation of three independent MEF preparations from littermate embryos. (**C**) Primary and immortalized WT and *Mdr2* ^*−/−*^ cells were synchronized by serum starvation and stimulated by 10% serum. Cell lysates were prepared at the indicated time after stimulation and analyzed by immunoblotting. Similar results were obtained with two other independent clones. (**D**) Increased cell proliferation in immortalized *Mdr2* ^*−/−*^ cells. Equal numbers of spontaneously immortalized WT and *Mdr2* ^*−/−*^ MEFs were plated in triplicate. Cell numbers were determined during 5 days. Data presented are the mean values ± standard deviation obtained from three independent cell cultures. The experiments were repeated with two other independent clones. The asterisk indicates significant difference between WT and KO. \*\**P* \< 0.005, Student's test. KO: Mdr2 knockout, HE: Mdr2 heterozygote. (**E**) Ectopic expression of Mdr2 in *Mdr2* ^*−/−*^ MEFs. *Mdr2* mRNA expression in WT MEFs, *Mdr2* ^*−/−*^ MEFs transfected with empty vector and *Mdr2* ^*−/−*^ MEFs transfected with vector expressing Mdr2 by qPCR. (**F**) Reduced cyclin D1 and cyclin A expression in *Mdr2* ^*−/−*^ cells after introduction of Mdr2 was detected by immunoblotting with anti-cyclin D1 and anti-cyclin A antibodies. (**G**) Growth curve of immortalized vector-transfected *Mdr2* ^*−/−*^ MEFs, Mdr2-transfected *Mdr2* ^*−/−*^ MEFs and WT MEFs. Equal numbers of cells were plated in triplicate at the beginning of the experiments. Cell numbers were determined every day for a total of 6 days. Data presented are the mean values ± standard deviation obtained from three independent cell cultures. The experiments were repeated with two other independent Mdr2-transfected *Mdr2* ^*−/−*^ pools. \*\**P* \< 0.005, Student's test. Primary (**H**) and immortalized (**I**) WT and *Mdr2* ^*−/−*^ MEFs were treated with increasing doses of Dox. Cell viability was analyzed by MTT assay. Data presented are the mean values ± standard deviation obtained from three independent experiments. The experiments were repeated with two other independent preparations of MEFs. a.u.: arbitrary unit. (**J**) Immortalized MEFs were treated with 0.5 μM Dox for different times. Cell viability was examined at indicated time points by MTT assay. \**P* \< 0.05, Student's test. KO: Mdr2 knockout cells. (**K**) Proteins were extracted from immortalized MEFs without treatment or with treatment of 0.5 μM Dox for 12h and analyzed by immunoblotting with anti-caspase-3 antibody. NS: non-specific.](carcin_bgv156_f0001){#F1}

To confirm that Mdr2 deficiency was directly involved in the phenotype, we re-expressed Mdr2 in primary *Mdr2* ^*−/−*^ MEFs at early passages ([Figure 1E](#F1){ref-type="fig"}) and assessed the effect of exogenous Mdr2 expression on cyclin D1, cylcin A and cell growth. Continuous passage of Mdr2-restored MEFs readily gave rise to established 3T3 cell lines. Restoration of Mdr2 in *Mdr2* ^*−/−*^ MEFs delayed cyclin D1 and cyclin A induction and decreased their levels of expression ([Figure 1F](#F1){ref-type="fig"}). In addition, exogenous expression of Mdr2 significantly decelerated cell growth ([Figure 1G](#F1){ref-type="fig"}).

As deregulation of cell proliferation is frequently associated with deregulation of cell death, we next examined the effects of Mdr2 deficiency on apoptosis. Treatment with Dox, an apoptosis inducer with a broad-spectrum antibiotic activity, caused a decrease of cell viability in both primary WT and *Mdr2* ^*−/−*^ MEFs in a dose-dependent manner with similar kinetics ([Figure 1H](#F1){ref-type="fig"}). In contrast, immortalized *Mdr2* ^*−/−*^ MEFs were more resistant to Dox-induced apoptosis, showing significant higher viability than WT counterparts when treated with 0.5 μM Dox or higher doses ([Figure 1I](#F1){ref-type="fig"} and [J](#F1){ref-type="fig"}). While analysis by immunoblotting readily revealed cleaved caspase-3 in WT cells treated with Dox, indicative of the activation of this critical executioner of apoptosis, the cleaved form of caspase-3 was barely detectable in *Mdr2* ^*−/−*^ MEFs ([Figure 1K](#F1){ref-type="fig"}). As a previous report showed that moderate increase in mRNA levels of *Mdr1a* and *Mdr1b* in murine breast cancer can cause Dox resistance ([@CIT0022]), we assessed expression of *Mdr1a* and *Mdr1b* in immortalized *Mdr2* ^*−/−*^ MEFs by qPCR. There was a trend but not significant increase in *Mdr1a* and *Mdr1b* expression in *Mdr2* ^*−/−*^ cells ([Supplementary Figure 1](http://carcin.oxfordjournals.org/lookup/suppl/doi:10.1093/carcin/bgv156/-/DC1), available at *Carcinogenesis* Online). Together, these results demonstrate that Mdr2 deficiency can increase cell proliferation as well as resistance to Dox-induced apoptosis.

Accumulation of ROS and increased lipid peroxidation in immortalized *Mdr2* ^*−/−*^ MEFS {#s13}
----------------------------------------------------------------------------------------

To gain insight into the impact of Mdr2 deficiency on gene expression at the whole genome level, we performed cDNA microarray of primary and immortalized *Mdr2* ^*−/−*^ and WT cells to identify genes differentially expressed. As expected, primary *Mdr2* ^*−/−*^ and WT cells exhibited undistinguishable expression profile. In contrast, 827 probe sets were revealed differentially expressed between WT and immortalized *Mdr2* ^*−/−*^ cells with FDR \< 0.1% as the criterion for differential expression. Pathway analysis using the Gene Ontology evidenced deregulation of genes involved in different biological processes. These include regulation of cell proliferation, positive regulation of biological processes, lipid metabolic process, regulation of cell differentiation, defense response, lipid biosynthetic process, oxidation reduction and fatty acid metabolism ([Supplementary Tables 1 and 2](http://carcin.oxfordjournals.org/lookup/suppl/doi:10.1093/carcin/bgv156/-/DC1), available at *Carcinogenesis* Online), which have been previously identified in *Mdr2* ^*−/−*^ liver ([@CIT0008],[@CIT0023],[@CIT0024]). Furthermore, in agreement with Katzenellenbogen *et al.* ([@CIT0023]), deregulation of expression of Jun, MCM4, MCM7 and Pparg involved in DNA replication was also observed in *Mdr2* ^*−/−*^ MEFs ([Supplementary Table 3](http://carcin.oxfordjournals.org/lookup/suppl/doi:10.1093/carcin/bgv156/-/DC1), available at *Carcinogenesis* Online).

Since ROS acts as critical signaling molecules in cell proliferation and survival, we set up to measure ROS production in immortalized MEFs. Cells were incubated with the probe H~2~DCFDA whose intracellular oxidation into the green fluorescein derivative 2,7-dichlorofluorescein (DCF) served as indicator of ROS formation ([@CIT0025]). Analysis of the percentage of ROS-positive cells was carried out by flow cytometry. As shown in [Figure 2A](#F2){ref-type="fig"} and [B](#F2){ref-type="fig"}, immortalized *Mdr2* ^*−/−*^ cells displayed significantly higher levels of ROS than WT cells. We then treated cells with H~2~O~2~ for 1h and measured ROS-positive cells 1 and 6h post-treatment. Both WT and *Mdr2* ^*−/−*^ cells showed high levels in ROS contents at 1h point because of H~2~O~2~ addition ([Figure 2A](#F2){ref-type="fig"} and [B](#F2){ref-type="fig"}). Whereas WT cells almost eliminated all exogenous H~2~O~2~ 6h after treatment, large amount of exogenous H~2~O~2~ still remained in *Mdr2* ^*−/−*^ cells ([Figure 2A](#F2){ref-type="fig"} and [B](#F2){ref-type="fig"}), suggesting dysfunction of the antioxidant systems ([@CIT0026]). These findings are correlated with microarray data showing deregulation of gene expression in biological process of oxidative reduction (see [Supplementary Table 2](http://carcin.oxfordjournals.org/lookup/suppl/doi:10.1093/carcin/bgv156/-/DC1), available at *Carcinogenesis* Online).

![Reactive oxygen species (ROS) accumulation, increased lipid peroxidation and DNA damage in immortalized *Mdr2* ^*−/−*^ MEFs. (**A**, **B**) Cells were treated for 1h with 0.1mM H~2~O~2~. ROS accumulation was analyzed before treatment or 1 and 6h after treatment by flow cytometry. MFI: mean fluorescence intensity. \**P* \< 0.05, \*\**P* \< 0.005, Student's test. (**C**) Primary and immortalized MEF extract was quantified for malondialdehyde (MDA) using Colorimetric Assay. \*\**P* \< 0.005, Student's test. (**D**) Analysis by immunofluorescence of immortalized WT and *Mdr2* ^*−/−*^ MEFs with antibodies against γH2AX and 53BP1.](carcin_bgv156_f0002){#F2}

Oxidative stress occurs when the production of ROS exceeds their catabolism through either an increase in ROS levels or a decrease in the cellular antioxidant capacity. Oxidative stress results in direct or indirect ROS-mediated damage of lipids, proteins and nucleic acids. ROS can react with polyunsaturated fatty acids of lipid membranes and induces lipid peroxidation ([@CIT0027]). We thus measured the end product of lipid peroxidation MDA using colorimetric assay. As shown in [Figure 2C](#F2){ref-type="fig"}, while no significant difference in the production of MDA was detected between primary WT and *Mdr2* ^*−/−*^ cells, immortalized *Mdr2* ^*−/−*^ cells produced significantly higher levels of MDA than WT counterparts, attesting increased lipid peroxidation. ROS can cause double-strand DNA breaks, damaging DNA. The DNA damage-induced foci, marked by the histone variant H2AX phosphorylated on Ser139 (γH2AX) and the recruitment of chromatin-associated genome caretakers such as p53-binding protein 1 (53BP1), represent sites of DNA breaks. Analysis by immunofluorescence detected numerous positive foci of γH2AX and 53BP1 in the nucleus of *Mdr2* ^*−/−*^ cells in contrast to few foci in WT cells ([Figure 2D](#F2){ref-type="fig"}), indicative of DNA damage in *Mdr2* ^*−/−*^ cells.

Increased lipid peroxidation and DNA damage in *Mdr2* ^*−/−*^ liver {#s14}
-------------------------------------------------------------------

We next wanted to investigate how Mdr2 deficiency affected lipid peroxidation *in vivo.* To address it, liver tissues were dissected from *Mdr2* ^*−/−*^ and WT mice at different ages and were subjected to quantification of MDA. As shown in [Figure 3A](#F3){ref-type="fig"}, no difference was observed in MDA production between *Mdr2* ^*−/−*^ and WT livers from 2-week-old mice in which inflammation is not found yet ([@CIT0003]). However, at 2-month-old and 4-month-old when inflammation is present, *Mdr2* ^*−/−*^ livers generated significant higher levels of MDA than WT counterparts ([Figure 3A](#F3){ref-type="fig"}). Moreover, analysis by IHC in the 4-month-old liver revealed six-fold increase of γH2AX-positive cells and 30-fold increase of 53BP1-positive cells in *Mdr2* ^*−/−*^ mice, showing significant difference compared to the WT liver ([Figure 3B](#F3){ref-type="fig"} and [C](#F3){ref-type="fig"}). This result is in agreement with previous report ([@CIT0028]). DNA damage leads either to cell death or aberrant cell proliferation, which is one of the characteristics of cancer cells. In *Mdr2* ^*−/−*^ HCCs, we found dramatic increases in heterochromatin protein 1 isoform α (HP1α) abundance and Akt phosphorylation ([Figure 3D](#F3){ref-type="fig"}). HP1α is overexpressed in many types of cancer and its high level expression is associated with rapid cell proliferation ([@CIT0029]). Activation of the PI3K/Akt pathway results in a disturbance of control of cell growth and survival, which contributes to a competitive growth advantage.

![Increased lipid peroxidation and DNA damage in the *Mdr2* ^*−/−*^ liver. (**A**) Liver extract was prepared from 2-week-old, 2-month-old and 4-month-old mice and quantified for malondialdehyde (MDA) by Colorimetric Assay. Three mice were used for each genotype. The data are presented as the MDA quantity per mg of liver weight. \*\**P* \< 0.005, \*\*\**P* \< 0.0005, Student's test. (**B**) Immunostaining with antibodies against γH2AX and 53BP1 on liver sections of WT and *Mdr2* ^*−/−*^ mice (*n* = 4). (**C**) Fold increase of γH2AX- and 53BP1-positive cells in *Mdr2* ^*−/−*^ mice over WT mice. (**D**) Immunoblotting analysis of expression of HP1α and Akt and phosphorylation of Akt in three WT livers and paired tumorous (T) and non-tumorous (NT) liver tissues from four *Mdr2* ^*−/−*^ mice.](carcin_bgv156_f0003){#F3}

To gain insight into alterations of gene expression at the whole-genome level in *Mdr2* ^*−/−*^ liver, CAGE was performed using liver samples from 6 WT mice and 31 *Mdr2* ^*−/−*^ mice ([@CIT0030]). We analyzed CAGE data using a recently developed network-based approach ([@CIT0031]). Briefly, we first identified differentially expressed genes (DEGs) between WT and *Mdr2* ^*−/−*^ mice for a total of 5844 genes with FDR \< 1% and 8653 with FDR \< 5%. Due to the large number of significant genes, we used a co-expression network approach to identify significantly dysregulated pathways in *Mdr2* ^*−/−*^ mice. To this end, we first generated a coexpression network from all the 37 WT and *Mdr2* ^*−/−*^ CAGE-seq expression profiles where genes are connected to each other if they are significantly coexpressed across the samples according to a correlation measure. We then extracted from the subnetwork containing only the significant DEGs and identified 'communities' of densely interconnected genes. Finally, we performed Gene Ontology enrichment analysis for each of the community. The top enriched Biological Process terms include 'oxidation reduction', 'lipid biosynthetic process' and 'fatty acid metabolic process' ([Table 1](#T1){ref-type="table"}), which is in accordance with previous report showing alterations of gene expression in lipid metabolism in the liver of *Mdr2* ^*−/−*^ mice ([@CIT0008],[@CIT0024]). This network-based approach has the advantage to identify enriched biological processes with differentially expressed connected genes, even though the genes involved in the same biological process are not necessarily the same when they are from different communities ([Supplementary File 1](http://carcin.oxfordjournals.org/lookup/suppl/doi:10.1093/carcin/bgv156/-/DC1), available at *Carcinogenesis* Online).

###### 

Representation of communities of the *Mdr2* ^*−/−*^ CAGE

  ID   N1    N2   Gene Ontology   Biological process
  ---- ----- ---- --------------- --------------------------------------------------------
  1    259   19   GO:0055114      Oxidation reduction
  1    259   12   GO:0008610      Lipid biosynthetic process
  1    259   13   GO:0006631      Fatty acid metabolic process
  1    259   4    GO:0006695      Cholesterol biosynthesis process
  2    122   17   GO:0055114      Oxidation reduction
  2    122   7    GO:0008202      Steroid metabolic process
  3    200   32   GO:0055114      Oxidation reduction
  3    200   7    GO:0009309      Amine biosynthetic process
  4    127   11   GO:0010604      Positive regulation of macromolecule metabolic process
  5    27    7    GO:0051301      Cell division
  5    27    7    GO:0007049      Cell cycle

ID: the community identification number, N1: total number of genes in each community, N2: number of genes involved in the specified biological process, GO: Gene Ontology number.

Collectively, ablation of Mdr2 results in increased levels of lipid peroxidation and DNA damage in the liver.

Spontaneous transformation of *Mdr2* ^*-/*-^ MEFs {#s15}
-------------------------------------------------

To investigate direct impact of Mdr2 deficiency on cell transformation, we tested anchorage-independent growth of *Mdr2* ^*−/−*^ MEFs at different passages on 3T3 protocol by soft agar assays. As shown in [Figure 4A](#F4){ref-type="fig"} and [B](#F4){ref-type="fig"}, no colony developed in neither WT nor *Mdr2* ^*−/−*^ cells at passage 24, but strikingly, numerous colonies were detected at passage 38 in *Mdr2* ^*−/−*^ cells but not in WT cells. At passage 52, colonies were even more abundant in *Mdr2* ^*−/−*^ cells ([Figure 4A](#F4){ref-type="fig"}). Quantification showed that about 100 and 170 colonies were formed in a plate in *Mdr2* ^*−/−*^ cells at P38 and P52, respectively ([Figure 4B](#F4){ref-type="fig"}). Next, cells at passage 38 were analyzed for the loss of contact inhibition by focus formation assays. Loss of Mdr2 markedly augmented colony formation ([Figure 4C](#F4){ref-type="fig"}). The number of colonies per plate developed about 100 times more in *Mdr2* ^*−/−*^ cells than WT cells ([Figure 4D](#F4){ref-type="fig"}). When injected s.c. into BALB/c nude mice, transformed *Mdr2* ^*−/−*^ MEFs induced tumor formation in 10/10 mice, while no tumor developed in 10/10 mice injected with WT MEFs ([Figure 4E](#F4){ref-type="fig"} and [F](#F4){ref-type="fig"}). Together, these results indicate that deficiency of Mdr2 drives cell transformation.

![Spontaneous transformation in *Mdr2* ^*−/−*^ MEFs. (**A**, **B**) Soft agar assay of WT and *Mdr2* ^*−/−*^ MEFs at different passages. Data presented are the mean values ± standard deviation obtained from three independent cell cultures. The experiments were repeated with two other clones from independent MEF preparations. The asterisk indicates significant difference between *Mdr2* ^*−/−*^ and WT cells at the same passage. \*\*\**P* \< 0.0005, Student's test. (**C**, **D**) Focus formation assay of WT and *Mdr2* ^*−/−*^ MEFs at passage 38. Data presented are the mean values ± standard deviation obtained from three independent cell cultures. The experiments were repeated with two other clones from independent MEF preparations. The asterisk indicates significant difference between *Mdr2* ^*−/−*^ and WT cells when seeded with the same number of cells. \*\*\**P* \< 0.0005, Student's test. (**E**, **F**) Tumorigenicity of transformed *Mdr2* ^*−/−*^ MEFs in athymic BALB/c mice. Data presented are the mean values ± standard deviation obtained from two flanks of five mice. The experiments were repeated once.](carcin_bgv156_f0004){#F4}

Deletion of Mdr2 increases intestinal polyposis in a mouse model of colitis-associated cancer {#s16}
---------------------------------------------------------------------------------------------

To determine the *in vivo* effects of Mdr2 deficiency on cell transformation in other tissues than the liver, we took advantage of the mouse model of AOM/DSS-induced intestinal tumorigenesis to investigate how Mdr2 affects the phenotype associated with AOM/DSS-induced cancer ([@CIT0032]). The protocol of AOM/DSS administration was applied to *Mdr2* ^*−/−*^ mice and their *Mdr2* ^*+/+*^ littermate control mice. Expression of Mdr2 mRNA in WT intestine was detectable by qPCR (data not shown). Because of enterohepatic circulation of bile, we first examined if the lack of phospholipids in the bile had impact on the intestine in *Mdr2* ^*−/−*^ mice. As shown in [Figure 5A](#F5){ref-type="fig"}--[D](#F5){ref-type="fig"}, deletion of Mdr2 did not alter crypt-villus architecture of the small intestine. Regardless of genotype, all mice treated with AOM plus DSS developed tumors, which were mostly adenomas with high-grade dysplasia ([Figure 5E](#F5){ref-type="fig"} and [H](#F5){ref-type="fig"}). However, we observed a seven-fold increase in tumor incidence in the *Mdr2* ^*−/−*^ group ([Figure 5I](#F5){ref-type="fig"}). We measured the sizes of polyps and showed that tumor sizes in *Mdr2* ^*−/−*^ group were larger than in the *Mdr2* ^*+/+*^ group ([Figure 5J](#F5){ref-type="fig"}). Precisely, there were proportionally more tumors in *Mdr2* ^*−/−*^ mice with sizes superior to 5mm than in WT mice ([Figure 5J](#F5){ref-type="fig"}). Together, these results suggest that Mdr2 is important in both tumor initiation and tumor growth.

![Deletion of Mdr2 increases intestinal tumor incidence. (**A**--**H**) Histological analysis of untreated and AOM/DSS treated intestines in WT and *Mdr2* ^*−/−*^ mice. (I) Total number of intestinal polyps was counted in 12 WT and 12 *Mdr2* ^*−/−*^ mice after AOM/DSS treatment. Compared to WT littermates, significant increase in poly number was observed in *Mdr2* ^*−/−*^ mice. \*\*\**P* \< 0.0005, Student's test. (J) Mdr2 deficiency enhances tumor growth. The percentage of total number of polyps in 12 WT and 12 *Mdr2* ^*−/−*^ mice with size inferior to 2mm, between 2 and 5mm and superior to 5mm is presented.](carcin_bgv156_f0005){#F5}

Discussion {#s17}
==========

Ablation of Mdr2 abolishes the PC transporter function causing bile defect-associated diseases including liver inflammation, hepatic fibrosis and HCC. It could also produce other pathogenic properties that contribute to cell proliferation, survival and tumorigenesis. Here, we explored the phenotypic effects of Mdr2 deficiency in MEFs and in chemical carcinogen-induced intestinal tumor and showed that Mdr2 is necessary to maintain ROS homeostasis. *Mdr2* ^*−/−*^ MEFs produce high levels of ROS leading to increased lipid peroxidation and DNA damage. These cells display enhanced proliferation, resistance to Dox-induced apoptosis and spontaneously undergo transformation at late passages. The phenotypes in MEFs are correlated with the findings in *Mdr2* ^*−/−*^ mice in which were observed enhanced levels of lipid peroxidation and DNA damage in the liver and increased susceptibility of carcinogen-induced tumor development in the intestine. These results contribute to the understanding of Mdr2 actions in pathogenesis and raise questions of potential extrahepatic behaviors of MDR3 mutations in human.

Most of our understanding of how deletion of *Mdr2* mediates its pathogenic activity has been derived from exploring the consequences of the bile defect in the liver. Whereas hepatic inflammation resulted from hepatocyte and cholangiocyte injury by toxic BAs in *Mdr2* ^*−/−*^ mice promotes production of ROS, oxidative DNA damage and reduced DNA repair ([@CIT0028]), the contribution of Mdr2 deficiency to pathogenesis is poorly understood. Here, we show that deletion of Mdr2 enhances ROS production in MEFs, fostering lipid peroxidation and DNA damage. Questions remain as to how the transporter of PC acts mechanistically in the regulation of ROS. Previous report showed that alterations in lipid metabolism and disruption of lipid homeostasis contribute to the pathogenesis and progression of cholestatic liver disease in *Mdr2* ^*−/−*^ mice ([@CIT0008]). We hypothesize that disruption of lipid homeostasis owing to *Mdr2* deletion may represent the major event with consequences throughout pathways involved in ROS production and catabolism and ROS-mediated damage repair ([@CIT0026]). This view is supported by gene expression profiling in MEFs by microarray and in *Mdr2* ^*−/−*^ HCCs by CAGE that revealed significant expression changes in genes involved in oxidative reduction, lipid biosynthesis and fatty acid metabolism. Furthermore, our preliminary results suggest increased levels of lipids in *Mdr2* ^*−/−*^ cells even though we have not been able to identify which specific species of lipids were changed.

It has long been known that lipid can serve as second message for signal transductions and mediate an array of cellular response including inflammation, cell proliferation and apoptosis ([@CIT0033]). Recently, specific species of PC have been identified as ligands for the nuclear receptors peroxisome proliferator-activated receptor a (PPARa) and the liver receptor homolog 1 (LRH-1) ([@CIT0034],[@CIT0035]), which not only are the key modulators of metabolism of glucose, lipid and BAs but also play important roles in carcinogenesis. Signaling through PPARa contributes to the upregulation of peroxisomal enzymes, such as acyl CoA oxidase, that produce the ROS H~2~O~2~ increasing oxidative stress. Besides, PPARa activation also leads to elevated hepatocellular proliferation and inhibition of apoptosis ([@CIT0036]). Double knockout of Mdr2 and PPARa protected animals from chronic liver injury, resulting in reduced bile duct proliferation and less fibrosis, whereas administration of PPARa activator fenofibrate in *Mdr2* ^*−/−*^ mice not only aggravated liver injury and fibrosis but also increased inflammation ([@CIT0008]), demonstrating a close link between PPARa-mediated signaling and the pathogenesis in *Mdr2* ^*−/−*^ mice. LRH-1 is a driving factor in development and progression of cancer, especially colon, pancreatic and breast cancers, by promoting cell growth and proliferation ([@CIT0037]). Thus nuclear receptor activation by PC ligands may constitute a mechanism for lipid second message signaling functions in carcinogenesis. Moreover, endonuclear PC biosynthesis supports cell proliferation ([@CIT0040]). Further study is needed to investigate the quantity, composition and cellular localization of PC species in *Mdr2* ^*−/−*^ cells and their impact on signal transductions.

Given the predominant and restricted functions of Mdr2 in bile formation, most of the pathologic properties of Mdr2 deficiency are thought to reflect toxic effects of BAs in the bile devoid of phospholipids. Indeed, previous work on the role of partial hepatectomy in HCC initiation and progression in *Mdr2* ^*−/−*^ mice suggests an accumulation of DNA double-strand breaks in the hepatocytes of the *Mdr2* ^*−/−*^ mice consequential to chronic inflammation ([@CIT0028]). Though inflammation is a crucial force to promote increase in ROS accumulation in *Mdr2* ^*−/−*^ liver, we identified additional effects of Mdr2 deficiency that also contribute to oxidative stress. However, the fact that only immortalized but not primary *Mdr2* ^*−/−*^ MEFs showed increased proliferation, ROS accumulation and alterations in gene expression profile suggests that a 'second hit' event is necessary to sustain Mdr2 deficiency-mediated oxidative stress. Our data provide evidence of broader functional roles of Mdr2, which is in line with previous report showing that Mdr2 is a modulator of glucose homeostasis ([@CIT0041]). Although we cannot exclude effects of abnormal bile composition in the increased propensity of *Mdr2* ^*−/−*^ mice to AOM/DSS-induced intestinal tumorigenesis, AOM treatment alone showed development of few tumors in the intestine of *Mdr2* ^*−/−*^ mice similar to WT animals (data not shown), suggesting that bile components may not be a determinant factor of intestinal tumor development in this setting.

The identification of broader functions of the PC transporters Mdr2/MDR3 may have impact on the appreciation of human diseases associated with MDR3 mutations. Although extrahepatic phenotypes have never been reported in patients harboring homozygous mutations in the *MDR3* gene ([@CIT0042]), analysis of potential effects of MDR3 defects in other tissues than the liver may provide full insight into disease pathogenesis. In particular, the question of whether the functions of immune cells are affected by MDR3 mutations may be worth to be addressed, as these cells express the *ABCB4* gene ([@CIT0010]) and are key factors in mediating inflammatory response in the diseased liver caused by MDR3 mutations.
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AOM

:   azoxymethane

BA

:   bile acid

CAGE

:   Cap Analysis of Gene Expression

DSS

:   dextran sodium sulfate

Dox

:   doxorubicin

FDR

:   false discovery rate

HCC

:   hepatocellular carcinoma

MDA

:   malondialdehyde

MEF

:   mouse embryonic fibroblasts

Mdr2

:   multidrug resistance 2
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PPARa

:   peroxisome proliferator-activated receptor a

ROS

:   reactive oxygen species

SCC

:   Spearman Correlation Coefficient
